Xiaoye Guo

F13A1 enhances temozolomide resistance in glioblastoma via activation of the NF-κB signalling pathway

Acquired resistance to temozolomide (TMZ) is a principal driver of therapeutic failure and tumour recurrence in glioblastoma (GBM). This study sought to elucidate the molecular underpinnings of this resistance, aiming to identify viable prognostic markers and therapeutic targets...